Assessing Type 2 Diabetes Risk in the Post-Pandemic Era: A Pharmacy-Led FINDRISC Screening Study
2024

Assessing Type 2 Diabetes Risk in the Post-Pandemic Era

Sample size: 494 publication Evidence: moderate

Author Information

Author(s): Victoria Bell, Ana Rita Rodrigues, Vera Costa, Catarina Dias, Márcia Alpalhão, Inês Martins, Mário Forrester, Alessia Verduri

Primary Institution: Faculty of Pharmacy, University of Coimbra, Portugal

Hypothesis

Can community pharmacies effectively assess the risk of type 2 diabetes in a post-pandemic population using the FINDRISC tool?

Conclusion

Community pharmacies can identify individuals at risk of developing type 2 diabetes using the FINDRISC tool, with 29.8% of participants classified as high or very high risk.

Supporting Evidence

  • 29.8% of participants were identified as high or very high risk for diabetes.
  • Lower educational levels were associated with higher diabetes risk.
  • Community pharmacies can effectively screen for diabetes risk using FINDRISC.

Takeaway

This study shows that pharmacies can help find people at risk for diabetes, which is important for keeping them healthy.

Methodology

A cross-sectional analytical study using convenience sampling in five community pharmacies, assessing participants with the FINDRISC questionnaire.

Potential Biases

Potential selection bias due to convenience sampling and social desirability bias in self-reported data.

Limitations

The study's findings may not be generalizable due to its convenience sampling method and reliance on self-reported data.

Participant Demographics

Participants were aged 40 or older, with 58.7% women and 41.3% men.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/life14121558

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication